Anastrozole
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C17H19N5 293.37
1,3-Benzenediacetonitrile, a,a,a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-;a,a,a',a'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile CAS RN: 120511-73-1; UNII: 2Z07MYW1AZ.
1 DEFINITION
Anastrozole contains NLT 98.0% and NMT 102.0% of anastrozole (CHN), calculated on the anhydrous and solvent-free basis.
2 IDENTIFICATION
Change to read:
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197K (CN1-MAY-2020)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
PROCEDURE
Solution A: Acetonitrile, methanol, trifluoroacetic acid, and water (100:300:0.5:600)
Solution B: Acetonitrile, methanol, trifluoroacetic acid, and water (150:450:0.5:400)
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 100 | 0 |
| 10 | 100 | 0 |
| 40 | 0 | 100 |
| 41 | 100 | 0 |
| 56 | 100 | 0 |
[NOTE-These gradient elution times are established on an HPLC system with a dwell time of approximately 0 min. The gradient elution times in the table can be adjusted by subtracting the dwell time to achieve the separation described.]
Standard solution: 0.5 mg/mL of USP Anastrozole RS prepared as follows. Transfer USP Anastrozole RS into a suitable volumetric flask.
Dissolve in acetonitrile, using 40% of the final volume, and then dilute with Solution A to volume.
Sample solution: 0.5 mg/mL of Anastrozole prepared as follows. Transfer 25 mg of Anastrozole to a 50-mL volumetric flask, add 20 mL of acetonitrile to dissolve. Dilute with Solution A to volume.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 215 nm
Column: 3.2-mm x 10-cm; 5-µm packing L42
Flow rate: 0.75 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: Between 0.9 and 1.4
Relative standard deviation: NMT 0.73%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of anastrozole (C17H19N5) in the portion of Anastrozole taken:
Result = (ru /rs ) × (Cs /Cu ) × 100
ru = peak area of anastrozole from the Sample solution
rs = peak area of anastrozole from the Standard solution
Cs = concentration of USP Anastrozole RS in the Standard solution (mg/mL)
Cu = concentration of Anastrozole in the Sample solution (mg/mL)
Acceptance criteria: 98.0%-102.0% on the anhydrous and solvent-free basis
4 IMPURITIES
RESIDUE ON IGNITION (281): NMT 0.1%
ORGANIC IMPURITIES
Solution A, Solution B, and Chromatographic system: Proceed as directed in the Assay.
Standard stock solution: 0.2 mg/mL of USP Anastrozole RS prepared as follows. Dissolve in acetonitrile, using 40% of the final volume, and then dilute with Solution A to volume.
Standard solution: 0.02 mg/mL of USP Anastrozole RS in Solution A from the Standard stock solution
Sample solution: 2 mg/mL of Anastrozole prepared as follows. Transfer 50 mg of Anastrozole to a 25-mL volumetric flask. Add 10 mL of acetonitrile. Dissolve in and dilute with Solution A to volume.
Blank solution: Transfer 10 mL of acetonitrile into a 25-mL volumetric flask, and dilute with Solution A to volume.
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: Between 0.9 and 1.4
Relative standard deviation: NMT 5%
Analysis
Samples: Standard solution, Sample solution, and Blank solution. [NOTE-Adjust the peak areas for any interference from the Blank solution.]
Calculate the percentage of each individual impurity in the portion of Anastrozole taken:
Result = (ru /rs ) × (Cs /Cu ) × 100
ru = peak area of each individual impurity from the Sample solution
rs = peak area of anastrozole from the Standard solution S
Cs = concentration of USP Anastrozole RS in the Standard solution (mg/mL)
Cu = concentration of Anastrozole in the Sample solution (mg/mL)
Acceptance criteria: See Table 2. Disregard any impurity of less than 0.05%.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Desmethyl anastrozolea | 0.6 | 0.2 |
| Anastrozole | 1.0 | - |
| Anastrozole dimerb | 2.0 | 0.2 |
| 5-Bromomethyl anastrozolec | 4.3 | 0.1 |
| 5-Dibromomethyl anastrozoled | 5.4 | 0.1 |
| Individual unspecied impurity | - | 0.1 |
| Total impurities | - | 0.5 |
a 2-(3-(1-Cyanoethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl)-2-methylpropionitrile.
b 2,3-Bis(3-(1-cyano-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl)-2-methylpropionitrile.
c 2,2′-(5-(Bromomethyl)-1,3-phenylene)bis(2-methylpropionitrile).
d 2,2′-(5-(Dibromomethyl)-1,3-phenylene)bis(2-methylpropionitrile).
5 SPECIFIC TESTS
Water Determination, Method Ic 〈921〉: NMT 0.3%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers. Store at room temperature.
USP Reference Standards 〈11〉
USP Anastrozole RS

